AnnaMed Overview

  • Founded
  • 2012
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

AnnaMed General Information


Developer of Annamycin drug. The company's Annamycin drug is a clinical stage pharmaceutical drug which provides treatment of acute myeloid leukemia, enabling leukemia patients to recover and lower their pain from acute cancer diseases.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • 1973 West Clay Street
  • Houston, TX 77019
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AnnaMed Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AnnaMed‘s full profile, request access.

Request a free trial